Clover Biopharmaceuticals, Ltd. (2197.HK)
Develops vaccines and protein-based medicines for infectious diseases and cancer.
1.67+0.01%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago+209.3%
The outlook
Clover Biopharmaceuticals is trading near its 52-week low, well below both its 50- and 200-day moving averages, signaling a downward trend. The stock's StockGlow score leans bearish, reflecting weak technical positioning. Analyst coverage appears limited based on available data.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range43% of the way from its 52-week low to high
Market cap
$2.17B
52-wk high
3.20
52-wk low
0.50
50-day avg
1.80
200-day avg
2.31
Trailing P/E
—